SCYNEXIS Files 8-K for Regulation FD Disclosure & Exhibits
Ticker: SCYX · Form: 8-K · Filed: Jan 5, 2024 · CIK: 1178253
| Field | Detail |
|---|---|
| Company | Scynexis Inc (SCYX) |
| Form Type | 8-K |
| Filed Date | Jan 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, compliance, 8-K
TL;DR
**SCYNEXIS filed a standard 8-K, signaling routine compliance and potential upcoming news.**
AI Summary
SCYNEXIS, Inc. filed an 8-K on January 5, 2024, to disclose information under Regulation FD and to include financial statements and exhibits. This filing, while routine, signals that the company is adhering to its reporting obligations and potentially preparing to release new material information. For investors, this matters because it indicates ongoing compliance and could precede significant announcements, impacting their decision to buy or sell SCYX stock.
Why It Matters
This filing ensures SCYNEXIS, Inc. is transparent with investors, fulfilling its regulatory duties and potentially setting the stage for future material disclosures.
Risk Assessment
Risk Level: low — This 8-K is a routine compliance filing and does not inherently introduce new risks or opportunities.
Analyst Insight
Investors should note this as a routine compliance filing. While it doesn't contain new material information itself, it confirms SCYNEXIS's adherence to regulatory standards and could precede future substantive announcements. Keep SCYNEXIS (SCYX) on your watchlist for any subsequent filings or press releases.
Key Players & Entities
- SCYNEXIS, Inc. (company) — the registrant filing the 8-K
- January 05, 2024 (date) — date of earliest event reported
- 001-36365 (other) — Commission File Number
- 56-2181648 (other) — IRS Employer Identification No.
- SCYX (other) — Trading Symbol on The Nasdaq Global Market
FAQ
What is the purpose of this 8-K filing by SCYNEXIS, Inc.?
SCYNEXIS, Inc. filed this 8-K to satisfy disclosure requirements under Regulation FD and to furnish financial statements and exhibits, as indicated by 'ITEM INFORMATION: Regulation FD Disclosure' and 'ITEM INFORMATION: Financial Statements and Exhibits'.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 05, 2024, as stated under 'Date of Report (Date of earliest event reported): January 05, 2024'.
What is the trading symbol for SCYNEXIS, Inc. and on which exchange is it registered?
SCYNEXIS, Inc.'s trading symbol is SCYX, and its Common Stock is registered on The Nasdaq Global Market, as detailed under 'Securities registered pursuant to Section 12(b) of the Act'.
What is the business address of SCYNEXIS, Inc. as listed in the filing?
The business address of SCYNEXIS, Inc. is 1 Evertrust Plaza, 13th Floor, Jersey City, New Jersey, 07302-6548, according to the 'BUSINESS ADDRESS' section of the filing.
Is SCYNEXIS, Inc. considered an emerging growth company according to this filing?
No, SCYNEXIS, Inc. is not indicated as an emerging growth company, as the box next to 'Emerging growth company' is unchecked (☐) in the filing.
Filing Stats: 488 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-01-05 09:53:32
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share SCYX The Nasdaq Global Ma
Filing Documents
- scyx-20240105.htm (8-K) — 40KB
- scyx-ex99_1.htm (EX-99.1) — 13KB
- scyx-ex99_1s1.jpg (GRAPHIC) — 313KB
- scyx-ex99_1s2.jpg (GRAPHIC) — 776KB
- scyx-ex99_1s3.jpg (GRAPHIC) — 342KB
- scyx-ex99_1s4.jpg (GRAPHIC) — 575KB
- scyx-ex99_1s5.jpg (GRAPHIC) — 534KB
- scyx-ex99_1s6.jpg (GRAPHIC) — 425KB
- scyx-ex99_1s7.jpg (GRAPHIC) — 365KB
- scyx-ex99_1s8.jpg (GRAPHIC) — 406KB
- scyx-ex99_1s9.jpg (GRAPHIC) — 237KB
- scyx-ex99_1s10.jpg (GRAPHIC) — 217KB
- scyx-ex99_1s11.jpg (GRAPHIC) — 318KB
- scyx-ex99_1s12.jpg (GRAPHIC) — 431KB
- scyx-ex99_1s13.jpg (GRAPHIC) — 300KB
- scyx-ex99_1s14.jpg (GRAPHIC) — 309KB
- 0000950170-24-002308.txt ( ) — 7812KB
- scyx-20240105_pre.xml (EX-101.PRE) — 10KB
- scyx-20240105_lab.xml (EX-101.LAB) — 13KB
- scyx-20240105.xsd (EX-101.SCH) — 2KB
- scyx-20240105_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 5, 2024, SCYNEXIS, Inc. (the “Company”) updated its investor slide presentation (“Corporate Presentation”). The Corporate Presentation is available on the Company’s website and is furnished as Exhibit 99.1 hereto. The information in this Item 7.01 and Exhibit 99.1 hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation 100 Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCYNEXIS, Inc. Date: January 5, 2024 By: /s/ David Angulo, M.D. Name: David Angulo, M.D. Its: Chief Executive Officer